Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
My experience within my department has been fantastic. Cross functional interactions have often been good. Experiences with the prior executive team make-up were, at times, excruciating. I have great hope for the executive new team, however.
O que faz você mais feliz no trabalho?
Being able to get things done for patients
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
It is stabilizing after years of being completely untenable. If I were based in the office, it is likely I would have moved on long ago.
Qual é a melhor parte das suas compensações?
Great $ matching. Healthcare is excellent although difficult to manage in NYS. Wishing that there were more options based on field distribution (at same level of quality).
Quais são algumas das melhores coisas da sua equipe?
My team in particular has been incredibly stable for the last 5 years which is totally a result of the quality of our department head and in the people that we have hired. They have become family, not just coworkers and we all collaborate REALLY well.
O que você mais gosta nos lideres?
The leadership team has become more stable over the last year. They seem to be realigning corporate strategy to that of a commercial entity rather than a start-up. The company culture has also become more stable and you can actually feel a collective sigh of relief.
Other Employee Reviews for Karyopharm Therapeutics
×